BioCentury
ARTICLE | Company News

Management tracks: Portola, Coherus

January 3, 2019 12:19 AM UTC

Hematology company Portola Pharmaceuticals Inc. (NASDAQ:PTLA) said SVP and CMO John Lawrence has resigned to pursue a new position with an undisclosed pharma company.

Coherus BioSciences Inc. (NASDAQ:CHRS) hired Darlene Horton as chief medical and regulatory affairs officer. Horton was CEO of TulangCo Inc. (San Francisco, Calif.) and CMO of SMC Biotechnology Inc. (Redwood City, Calif.). She succeeds former CMO Barbara Finck, who is now chief clinical adviser at the biosimilars company. ...